Less Survivable Cancers receive just 19% of research funding despite causing 40% of all cancer deaths
Today, the Less Survivable Cancers Taskforce (LSCT) has revealed alarming findings highlighting a critical lack of research funding for common but less survivable cancers. This stark imbalance is contributing to extremely poor outcomes for patients. Information, obtained from a series of Freedom of Information (FOI) requests, shows that research into the less survivable cancers – …
